{
    "SPADE_UN_14881": {
        "Clinical Information": [],
        "Patent Information": [],
        "Sequence Information": {
            "SPADE ID": "SPADE_UN_14881",
            "Peptide Name": "sHR2-4(derived from SARS-CoV spike protein heptad repeat)",
            "Source": "Synthetic construct(derived from SARS-CoV spike protein heptad repeat)",
            "Family": "Coronaviridae",
            "Gene": "Not found",
            "Sequence": "FKNHTSPDVDLGDISGINASVVNIQKEIDRLNEVAKNLNESLIDLQELGKYE",
            "Sequence Length": 52,
            "UniProt Entry": [
                "http://www.uniprot.org/uniprot/P59594"
            ],
            "Protein Existence": "Not found",
            "Biological Activity": [
                "Antimicrobial",
                "Antiviral"
            ],
            "Target Organism": "[Ref.15150417]SARS-CoV:inhibition of virus infection in Vero cells(EC50>50 Î¼M).",
            "Hemolytic Activity": "No hemolysis information or data found in the reference(s) presented in this entry",
            "Cytotoxicity": "No cytotoxicity information found in the reference(s) presented",
            "Binding Target": "membrane",
            "Linear/Cyclic": "Linear",
            "N-terminal Modification": "Free",
            "C-terminal Modification": "Free",
            "Stereochemistry": "L",
            "Structure Description": "Not found",
            "Formula": "C252H409N69O87",
            "Mass": 5797.35,
            "PI": 4.55,
            "Net Charge": -4,
            "Hydrophobicity": -0.5,
            "Half Life": "Mammalian:1.1 hourYeast:3 minE.coli:2 min",
            "Mechanism of action": "The peptide exhibits antiviral activity by competitive binding to the HR4 region of the SARS-CoV spike protein, thus blocking the formation of the six-helix bundle and consequently membrane fusion.",
            "Literature": [
                {
                    "Title": "Severe acute respiratory syndrome coronavirus (SARS-CoV) infection inhibition using spike protein heptad repeat-derived peptides.",
                    "Pubmed ID": "15150417",
                    "Reference": "Proc Natl Acad Sci U S A. 2004 Jun 1;101(22)8455-60.",
                    "Author": "Bosch BJ, Martina BE, Van Der Zee R, Lepault J, Haijema BJ, Versluis C, Heck AJ, De Groot R, Osterhaus AD, Rottier PJ.",
                    "URL": "http://www.ncbi.nlm.nih.gov/pubmed/?term=15150417"
                }
            ],
            "Frequent Amino Acids": "LND",
            "Absent Amino Acids": "CMOUW",
            "Basic Residues": 6,
            "Acidic Residues": 10,
            "Hydrophobic Residues": 20,
            "Polar Residues": 26,
            "Positive Residues": 6,
            "Negative Residues": 10,
            "Similar Sequences": [
                {
                    "SPADE_ID": "SPADE_UN_14878",
                    "Similarity": 1.0,
                    "Sequence": "ELDSPKEELDKYFKNHTSPDVDLGDISGINASVVNIQKEIDRLNEVAKNLNESLIDLQELGKYE"
                },
                {
                    "SPADE_ID": "SPADE_UN_14879",
                    "Similarity": 1.0,
                    "Sequence": "PKEELDKYFKNHTSPDVDLGLGDISGINASVVNIQKEIDRLNEVAKNLNESLIDLQELGKYE"
                },
                {
                    "SPADE_ID": "SPADE_UN_14880",
                    "Similarity": 1.0,
                    "Sequence": "LDKYFKNHTSPDVDLGDISGINASVVNIQKEIDRLNEVAKNLNESLIDLQELGKYE"
                }
            ]
        }
    }
}